Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perineural Dexmedetomidine as an Adjuvant to Bupivacaine-induced Ultrasound-guided Femoral Nerve Block.

NCT01964040 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT01964040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01964040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perineural Dexmedetomidine as an Adjuvant to Bupivacaine-induced Ultrasound-guided Femoral Nerve Block.
Lead sponsor
Cairo University
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2013
Completion date
January 31, 2014
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

onset and duration of sensory and motor block of femoral nerve,, time to first request of rescue analgesics,, total morphine consumption in 24 hours, visual analogue pain scores,